2024-11-12  9:51:04 PM Chg. +0.420 Volume Bid9:59:58 PM Ask9:59:58 PM Market Capitalization Dividend Y. P/E Ratio
110.000EUR +0.38% 253
Turnover: 27,840.680
109.480Bid Size: 138 109.760Ask Size: 138 189.53 bill.EUR - -

Business description

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 160 countries.
 

Management board & Supervisory board

CEO
Robert B. Ford, Daniel Salvadori
Management board
Robert E. Funck, Jr., Hubert L. Allen, John M. Capek, Lisa D. Earnhardt, John F. Ginascol, Joseph Manning, Mary K. Moreland, Andrea Wainer, Gregory A. Ahlberg, Christopher J. Calamari, Michael D. Dale, J. Scott House, Sammy Karam, Fernando Mateus, Louis H. Morrone, Michael J. Pederson, Julie L. Tyler, Jared L. Watkin, Alejandro D. Wellisch, Randel W. Woodgrift
Supervisory board
Robert B. Ford, Daniel J. Starks, Darren W. McDew, Dr. Sally E. Blount, John G. Stratton, Michael F. Roman, Michelle A. Kumbier, Nancy McKinstry, Robert J. Alpern, Claire Babineaux-Fontenot, William A. Osborn, Glenn F. Tilton, Paola Gonzalez
 

Company data

Name: Abbott Laboratories
Address: 100 Abbott Park Road,Abbott Park Illinois, Chicago 60064-3500, USA
Phone: +1-224-667-6100
Fax: -
E-mail: -
Internet: www.abbott.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 87.10%
IPO date: 1972-06-01

Investor relations

Name: Scott Leinenweber
IR phone: +1-224-667-8945
IR Fax: -
IR e-mail: -

Main Shareholders

Others
 
62.23%
Vanguard Group
 
8.99%
BlackRock Inc.
 
7.70%
CAPITAL RESEARCH GLOBAL INVESTOR
 
4.97%
State Street Corporation
 
4.29%
Capital International Investors
 
3.69%
Morgan Stanley
 
2.06%
GEODE CAPITAL MANAGEMENT LLC
 
1.88%
Wellington Management Group
 
1.85%
Others
 
2.34%